Prawo i regulacje · 14/08/2023

Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Review of Proposed Transaction

The Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which is expected to close in the second half of 2023